ConditionMoyamoya Disease
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age1-18
SponsorSeoul National University Hospital
About this trial
This prospective randomized controlled trial evaluates whether individualized cardiac index-guided intraoperative hemodynamic management reduces postoperative transient ischemic episodes in pediatric patients undergoing encephaloduroarteriosynangiosis (EDAS) for Moyamoya disease. Patients are randomized 1:1 to goal-directed fluid therapy based on baseline cardiac index versus standard arterial pressure-based management. The primary outcome is the incidence of transient ischemic episodes during hospitalization.
Eligibility criteria
Qualifiers
Pediatric patients <18 years undergoing EDAS for Moyamoya disease under general anesthesia
Disqualifiers
ASA physical status 4-5
Emergency surgery
Known cardiovascular disease
Any condition judged inappropriate by investigators
Trial design
Treatments tested in this trial
- Cardiac Index-Guided Hemodynamic Management
- Blood Pressure-Guided Standard Hemodynamic Management
Treatment groups
94 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov